trial
as of 2026-07-01A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia
NCTId NCT00483964
at a glance
Phase 2 · Completed
Enrollment 200 (actual)
Sponsored by Q.Mundewadi Ayurvedic Research & Charitable Trust
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 2
Status
Completed
Enrollment
200 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2005-09
Primary completion
—
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
Stanley Medical Research InstituteCollaborator
Investigators
1
AbdulMubeen A Mundewadi, B.A.M.S.Principal Investigator
Sites
1 total
Mumbra,Thane, India
Facts & assertions
3 sourced
Enrollment
200
Phase
PHASE2
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
indication
indication
investigator